The Walden Group - aVenture Asset Manager Research
Location
Tarrytown, NY, US
Founded
1990
The Walden Group is a strategic healthcare merger & acquisition advisory firm specializing in medical technologies. They focus on providing M&A services for privately owned medical technology companies, particularly those founded by industry pioneers. The firm's expertise spans corporate sales, divestitures, acquisition searches, and strategic consulting.
With over 30 years of experience, The Walden Group employs a full-immersion approach, going "all-in" for their clients. Their portfolio includes companies like Elitra Pharmaceuticals, Lexicon Pharmaceuticals, and V2 Ventures. The firm's unique value proposition lies in its deep industry knowledge and customized strategies for each client in the healthcare and medical technology sectors.
The Walden Group - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series B2 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
